Introduction
============

Life-threatening ventricular arrhythmias after resuscitation from aborted sudden cardiac death (SCD) in patients with coronary artery spasm are a major problem in the clinical setting ([@B1]). Under optimal medical therapy, including calcium-channel antagonists or nitrates, in the majority of cases, coronary spastic angina shows a good clinical course, whereas patients with aborted SCD due to coronary artery spasm may have a poor prognosis ([@B2]-[@B6]). Implantable cardioverter-defibrillators (ICDs) have been effective in patients with structural heart disease and ventricular fibrillation ([@B7]). The majority of the clinical reports published in the recent era concluded that ICDs were useful in patients with aborted SCD due to coronary artery spasm ([@B8]-[@B11]). However, although these patients received optimal medical therapy, we had no data about the appropriate ICD shocks that were administered to patients with aborted SCD due to coronary spasm after ICD implantation. We analyzed the past reports about appropriate ICD shocks and the medications that were administered after ICD implantation in patients with aborted SCD due to coronary artery spasm. We also compared the rates of appropriate ICD shocks and medications in patients from Western and Asian countries.

Materials and Methods
=====================

Study subjects
--------------

We extracted the papers published about ICD implantation in patients with coronary spastic angina from the PubMed database. We were able to analyze 137 patients who underwent the implantation of an ICD after the aborted SCD due to coronary artery spasm. Among the 137 patients, one patient had coronary artery spasm and Burgada syndrome, another patient had cocaine-induced spasm and one underwent ICD implantation after the implantation of a sirolimus-eluting stent (Cypher). We investigated the frequency of appropriate ICD shocks and compared the coronary risk factors, arteries with proven spasm, the medications and the prognosis after the implantation of ICD between patients with and without appropriate ICD shocks. Moreover, we compared Western and Asian patients with aborted SCD due to coronary artery spasm after ICD implantation, because coronary artery spasm has been reported to occur more frequently in Asian countries than in Western countries.

Statistical analysis
--------------------

All of the data were presented as the mean±1 standard deviation (SD). All of the categorical variables were analyzed by Fisher\'s exact test with correction or by the Mann-Whitney U test. p values of \<0.05 were considered to indicate statistical significance.

Results
=======

Appropriate ICD shocks
----------------------

As shown in [Table 1](#t001){ref-type="table"}, 137 patients underwent ICD implantation after aborted SCD due to coronary artery spasm ([@B8]-[@B38]). During the follow-up period (41±28 months), appropriate ICD shocks were observed in 33 patients (24.1%). However, the remaining 104 patients (75.9%) had no ICD shocks. All 33 patients had second ventricular tachycardia, fibrillation, or pulseless electrical activity, and appropriate ICD shocks successfully resuscitated 33 patients. Three patients were not successfully resuscitated. Inappropriate ICD shocks were observed in four patients (2.9%) for sinus tachycardia (n=2) or the double counting of the QRS by the ICD. Multiple appropriate ICD shocks were observed in 10 (30.3%) of the 33 patients; the mean number of appropriate ICD shocks among these 10 patients was 2.6±1.1.

###### 

Appropriate Implantable Cardioveter-defibrillator Shocks in Patients with Aborted Sudden Cardiac Death Due to Coronary Artery Spasm.

  -----------------------------------------------------------------------------------------------------
  Reference   Patient number of ICD\   Follow-up duration            Patient number with\     
              implantation                                           appropriate ICD shocks   
  ----------- ------------------------ ----------------------------- ------------------------ ---------
  12          2                        4 m/11 m                      2                        (100%)

  13          1                        2 m                           0                        

  14          1                        \-                            1                        (100%)

  11          7                        3.5±3.2 year                  4                        (57.1%)

  15          1                        6 m                           0\*                      

  16          1                        18 m                          0                        

  17          1                        4 m                           1                        (100%)

  18          1                        1 day                         1                        (100%)

  19          1                        14 m                          0                        

  20          1                        18 m                          0                        

  10          1                        6 m                           0                        

  21          1                        2 m                           0                        

  22          1                        24 m                          0                        

  23          1                        3 m                           1                        (100%)

  24          12                       19 m (1-48 m)                 1\*\*                    (8.3%)

  25          1                        12 m                          1 \*\*\*                 (100%)

  26          14                       32 m (17-46 m)                2                        (14.3%)

  8           23                       2.9 years (median 2.1 year)   4                        (17.4%)

  27          13                       17±14 m (1-40 m)              1                        (7.7%)

  28          14                       69±82 m                       5                        (35.7%)

  29          1                        24 m                          1                        (100%)

  30          2                        12 m                          0                        

  31          1                        12 m                          0                        

  32, 33      2                        36 m                          1                        (50%)

  34          1                        \-                            0\*                      

  35          6                        18±23 m (6-60 m)              0                        

  36          1                        24 m                          0\*                      

  37          1                        \-                            1 \*\*\*\*               (100%)

  38          24                       7.5 years (4.0-11.8 years)    6                        (25%)

  Total       137                      41±28 m                       33                       (24.1%)
  -----------------------------------------------------------------------------------------------------

\*: after percutaneous coronary intervention, \*\*: with Burgada syndrome, \*\*\*: cocaine induced, \*\*\*\*: after SES (Cypher)

ICD: implantable cardioverter-defbrillator, m: month

Coronary risk factors
---------------------

As shown in [Table 2](#t002){ref-type="table"}, we could only analyze the coronary risk factors in 43 (31.4%) patients; the records of the remaining 94 patients were missing data about coronary risk factors. Appropriate ICD shocks were observed in 7 (16.3%) of 43 patients, while the remaining 36 patients (83.7%) received no ICD shocks. The rates of male sex and a history of smoking in patients without appropriate ICD shocks were significantly higher than in those with appropriate ICD shocks.

###### 

Comparisons of Coronary Risk Factors between Patients with and without Appropriate Implantable-cardioverter Defibrillator Shocks.

                       With appropriate ICD shocks   Without appropriate ICD shocks   p value
  -------------------- ----------------------------- -------------------------------- ---------
  Number of patients   7                             36                               
  Age (y)              46.7±10.1                     50.3±13.3                        0.075
  Male                 3 (42.9%)                     32 (88.9%)                       0.019
  History of smoking   3 (42.9%)                     31 (86.1%)                       0.038
  Hypertension         3 (42.9%)                     11 (30.6%)                       0.845
  Dyslipidemia         1 (14.3%)                     10 (27.8%)                       0.783
  Diabetes mellitus    0                             1 (2.8%)                         0.355

ICD: implatable-cardioverter debrillator

Provable artery spasm
---------------------

We could only analyze the 63 (45.6%) cases involving provable artery spasm. These included 24 Western patients and 39 Asian patients. Appropriate ICD shocks were observed in 19 patients, while 44 patients had no appropriate ICD shocks. The incidence of provable spasm in each of the three coronary arteries did not different between the patients with and without appropriate ICD shocks \[right coronary artery (RCA): 68.4% (11/19) vs. 50.0% (22/44), ns, left circumflex artery (LCX): 57.9% (11/19) vs. 50.0% (22/44), ns, left anterior descending artery (LAD): 63.2% (12/19) vs. 72.7% (32/44), ns\]. Moreover, the rates of provable spasm in each of the three coronary arteries of patients with appropriate ICD shocks did not differ between Western and Asian patients \[RCA: 81.8% (9/11) vs. 50.0% (4/8), ns, LCX: 45.5% (5/11) vs. 75.0% (6/8), ns, LAD: 54.5% (6/11) vs. 75.0% (6/8), ns\].

Pharmacological spasm provocation tests
---------------------------------------

Pharmacological spasm provocation tests were performed in 55 (40.1%) patients, including 4 Western and 51 Asian patients. Invasive spasm provocation tests were performed significantly more frequently in Asian countries than in Western countries \[46.8% (51/109) vs. 14.3% (4/28), p\<0.01\], while spasm provocation tests in both the RCA and LCA were performed significantly more frequently in Asian countries than in Western countries \[22.0% (24/109) vs. 3.6% (1/28), p\<0.05\]. However, angiographic spontaneous spasm observed significantly more frequently in Western countries than in Asian countries \[35.7% (10/28) vs. 0.9% (1/109), p\<0.001\].

Medications in patients with appropriate ICD shocks
---------------------------------------------------

[Table 3](#t003){ref-type="table"} shows the medications in 33 patients with appropriate ICD shocks. We could not analyze the medications in 11 patients (33.3%) because of missing data. Only 5 patients (15.2%) received 2 or 3 calcium-channel antagonists, while 17 patients (51.5%) had were treated with a single calcium-channel antagonist. Nitrates or nicorandils were administered to 13 patients (39.4%). Only one patient (3%) was treated with triple calcium-channel antagonists. Seven patients (31.8%) were treated with 1 vasodilator, 10 (45.5%) patients were treated with 2 vasodilators and 5 (22.7%) patients were treated with 3 vasodilators.

###### 

Medications and Spasm Sites in Aborted Coronary Spastic Angina Patients with Appropriate Implantable Cardioveter-defibrillator Shocks.

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Reference           Age/\   No of pts   Spasm vessel           Follow-up\   Medication
                      Sex                                        duration     
  ------------------- ------- ----------- ---------------------- ------------ -------------------------------------------------------------------
  Western countries                                                           

  12                  56/M    1           LAD/ RCA               4 m          CCB (unknown)

                      36/F    1           LCX/RCA                11 m         Diltiazem (dose unknown)

  14                  60/M    1           LAD                    unknown      unknown

  11                  42/M    1           LAD/LCX/RCA            25 m         Diltiazem 60 mg, Verapamil 80 mg, ISDN 80 mg,

                      42/M    1           LAD/LCX/RCA            60 m         Diltiazem 60 mg, Verapamil 80 mg, Nifedipine 40 mg

                      46/M    1           RCA                    18 m         Diltiazem 120 mg

                      47/M    1           LAD/RCA                120 m        Nifedipine 30 mg, Verapamil 120 mg, ISMN 20 mg

  17                  50/M    1           RCA                    4 m          Amlodipine

  18                  40/F    1           RCA/LAD                1 day        unknown

  23                  38/F    1           LCX                    3 m          CCB (unknown), nitrate (unknown)

  25                  54/M    1           RCA                    12 m         CCB & nitrates (maximum dose)

  32, 33              52/F    1           LAD/LCX                36 m         Amlodipine 10 mg, Nifedipine 30 mg, Nicorandil 10 mg

  Asian countries                                                             

  24                  57/M    1           unknown                25 m         Benijipine 2 mg

  26                          2           unknown                unknown      unknown

  8                           4           LAD(4)/LCX(5)/RCA(3)   unknown      Diltiazem (5), ISMN (2), nicorandil (2)

  27                  33/M    1           LAD                    6 m          Diltiazem 200 mg, ISMN 40 mg

  28                          5           unknown                unknown      CCBs (5), nitrates or nicolandil (3)

  29                  53/F    1           RCA/LCX                3 m          Diltiazem 240 mg, ISMN 40 mg, Nicorandil 15 mg, Amiodarone 200 mg

  37                  57/M    1           LAD                    unknown      unknown

  38                          6           unknown                unknown      unknown
  -----------------------------------------------------------------------------------------------------------------------------------------------

M: male, F: female, No of pts: Number of patients, LAD: left anterior descending artery, LCX: left circumflex artery, RCA: right coronary artery, m: month, ISDN: isosorbide dinitrate, ISMN: isosorbide mononitrate, CCB: calcium channel blocker

The medications in patients without appropriate ICD shocks
----------------------------------------------------------

[Table 4](#t004){ref-type="table"} shows the medications that were administered to 104 patients without appropriate ICD shocks. Two or three calcium-channel antagonists were administered to just 10 patients (9.6%), whereas 62 patients (59.6%) were treated with a single calcium-channel antagonist. Nitrates or nicorandils were administered to 55 patients (52.9%). No patients were treated with triple calcium-channel antagonists. Detailed medication information was not available for 30 patients (28.9%). Twelve patients (16.2%) were treated with one vasodilator, while 39 (52.7%) patients received 2 vasodilators or 14 (18.9%) patients received 3 vasodilators. Moreover, 2 (2.7%) patients received no medications, while 3 (4.1%) patients were treated with four vasodilators.

###### 

Medications and Spasm Sites in Aborted Coronary Spastic Angina Patients without Appropriate Implantable Cardioveter-defibrillator Shocks.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference           Age/Sex        No of\   Spasm vessel      Follow-up\                  Medication
                                     pts                        duration                    
  ------------------- -------------- -------- ----------------- --------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Western countries                                                                         

  13                  70/M           1        LAD/ LCX          2 m                         Verapamil 180 mg, ISMN 60 mg

  11                  40/M           1        LAD               60 m                        Nifedipine 30 mg, Diltiazem 60 mg, Verapamil 120 mg, ISDN 20 mg

                      53/M           1        LAD               3 m                         Verapamil 240 mg, ISDN 50 mg

                      68/M           1        LAD               27 m                        Diltiazem 60 mg, Amlodipine 10 mg, ISDN 40 mg

  15                  47/F           1        LAD               6 m                         Verapamil 320 mg, Transdermal NTG 15 mg

  16                  60/M           1        RCA               18 m                        Diltiazem dose unknown, Nitrates dose unknown

  19                  49/M           1        LAD/LCX           14 m                        Amlodipine 10 mg, Transdermal Nitrate 5 mg

  20                  50/M           1        LAD/RCA           18 m                        CCB unknown

  10                  58/F           1        RCA               6 m                         Nifedipine dose unknown

  21                  Middle age/F   1        LCX               2 m                         CCB unknown, Nitrates unknown

  22                  46/M           1        unknown           24 m                        Diltiazem dose unknown, ISMN dose unknown

  30                                 2        LAD & LCX         12 m                        Amlodipin & metropolo (1), CCB & nitrate (1)

  32, 33              54/M           1        LMT               18 m                        Nifedipine 30 mg, Verapamil 240 mg

  34                  54/M           1        LAD               \-                          CCB unknown. Long-acting nitrate unknown

  36                  59/M           1        RCA               24 m                        Nifedipine 60 mg, ISMN 60 mg

  Asian countries                                                                           

  24                                 11       unknown           18.5±12.5 m                 Benidipine 2/4/8 mg (1/2/2), Benidipine 8 mg/Diltiazem 200 mg (2), Diltiazem 200 mg (1), Amlodipine 5 mg (1), CCB (-) (2)

  26                                 12       unknown           unknown                     unknown

  8                                  19       LAD(11)/\         2.9 year(median 2.1 year)   Diltiazem (19), ISMN (13), Nicorandil (10)
                                              LCX(12)/RCA(18)                               

  27                                 12       LAD(12/LCX(6)/\   18±14 m                     Diltiazem 200 mg & ISMN 40 mg (2), Diltiazem 200 mg/Nicorandil 10-20 mg/ ISMN 20-40 mg (5), Diltiazem 200 mg/Benidipien 8 mg/ Nicorandil 15-20 mg/ISMN 40-80 mg (2), Diltiazem 200 mg/Benidipine 16 mg/ Nicorandil 20 mg (1), Diltiazem 200 mg/Nifedipien 20 mg/ Nicorandil 20 mg/ISMN 40 mg (1), Nifedipine 20 mg & Amlodipine 5 mg (1)
                                              RCA(1)                                        

  28                                 9        unknown           69±82 m                     CCBs (9), nitrates or nicorandils (6)

  31                  68/M           1        RCA               12 m                        Diltiazem 400 mg, ISDN 40 mg, Nicorandil 15 mg

  35                                 6        unknown           18±23 m                     Nifedipine CR 40/60 mg & ISDN 40 mg (2/1), Nifedipine 40 mg & Nicorandil 15 mg (1), Amlodipine 5 mg & ISDN 40 mg (1), Diltiazem R 200 mg ISDN 40 mg Nicorandil 15 mg (1)

  38                                 18       unknown           unknown                     unknown
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M: male, F: female, No of pts: Number of patients, LAD: left anterior descending artery, LCX: left circumflex artery, RCA: right coronary artery, LMT: left main trunk, m: month, ISDN: isosorbide dinitrate, ISMN: isosorbide mononitrate, CCB: calcium channel blocker, ( ): number of patient

The medications and appropriate ICD shocks in patients from Western and Asian countries
---------------------------------------------------------------------------------------

The rate of appropriate ICD shocks was significantly higher among patients from Western countries than those from Asian countries (42.9% vs, 19.3%, p\<0.01), as shown in [Fig. 1](#g001){ref-type="fig"}. However, the medications that were administered after the implantation of an ICD in patients with aborted SCD due to coronary spasm did not differ between patients from Western and Asian countries.

![The rates of appropriate ICD shocks in Western and Asian countries. ICD: implantable cardioverter-defibrillator](1349-7235-57-1361-g001){#g001}

The medications administered to patients with and without appropriate ICD shocks
--------------------------------------------------------------------------------

As shown in [Table 5](#t005){ref-type="table"}, the medications in patients with appropriate ICD shocks did not differ from those in patients without appropriate ICD shocks. One calcium-channel antagonist was administered to 77.3% of the patients with appropriate ICD shocks, whereas 83.8% of the patients without appropriate ICD shocks were treated with 1 calcium-channel antagonist. In contrast, more than 3 vasodilators were administered to 22.7% of the patients with appropriate ICD shocks, while 24.3% of the patients without appropriate ICD shocks were treated with three or four vasodilators. We could only analyze the dosage of calcium-channel antagonists and nitrates/nicorandils in 45 (32.8%) patients ([Table 6](#t006){ref-type="table"}). Diltiazem and nicorandil were often administered to patients in Asian countries, while verapamil was most frequently administered in Western countries. However, with the exception of diltiazem, the dosages did not differ between the two countries. Eight patients were treated with amiodarone, including one patient with appropriate ICD shock.

###### 

Comparisons of Medications in Patients with Aborted Sudden Cardiac Death with and without Appropriate Implantable Cardioverter-defibrillator Shocks.

                          With appropriate ICD shocks             Without appropriate ICD shocks             p value                                                                                              
  ----------------------- ----------------------------- --------- -------------------------------- --------- --------- --------- -------- ---- -------- --------- -------- --------- ------- --------- ------- -- -------
  Medication unknown      11                            2         9                                                    30        0        30                                                                      
  Medication known        22                            10        12                                                   74        16       58                                                                      
  1 Ca                    17                            (77.3%)   6                                (60.0%)   11        (91.7%)   0.209         62       (83.8%)   13       (81.2%)   49      (84.5%)   0.756      0.482
  2 Ca                    4                             (18.1%)   3                                (30.0%)   1         (8.3%)    0.156         10       (13.5%)   3        (18.8%)   7       (12.1%)   0.780      0.733
  3 Ca                    1                             (4.5%)    1                                (10.0%)   0         0.925              0    0        0                            0.517                        
  Nitrate or nicorandil   13                            (59.1%)   5                                (50%)     8         (66.7%)   0.721         55       (74.3%)   12       (75.0%)   43      (74.1%)   0.944      0.167
  No medication           0                             0         0                                                    2         (2.7%)   0    2        (3.4%)    0.906              0.943                        
  1 vasodilator           7                             (31.8%)   4                                (40.0%)   3         (25.0%)   0.769         12       (16.2%)   2        (12.5%)   10      (17.2%)   0.942      0.106
  2 vasodilators          10                            (45.6%)   2                                (20.0%)   8         (66.7%)   0.078         42       (56.8%)   12       (75.0%)   30      (51.7%)   0.167      0.350
  3 vasodilators          5                             (22.7%)   4                                (40.0%)   1         (8.3%)    0.209         14       (18.9%)   1        (6.3%)    13      (22.4%)   0.270      0.693
  4 vasodilators          0                             0         0                                                    4         (5.4%)   1    (6.3%)   3         (5.2%)   0.865             0.612                
  Total                   33                            12        21                                                   104       16       88                                                                      

Ca: calcium channel antagonist, ICD: implantable cardioverter-defibrillator

###### 

Comparisons of Dose of Calcium-channel Antagonists and Nitrates/nicorandil in Patients with Aborted Sudden Cardiac Death with and without Appropriate Implantable Cardioverter-defibrillator Shocks.

                            With appropriate ICD shocks            Without appropriate ICD shocks      Total             p value                           
  ------------------------- ----------------------------- -------- -------------------------------- -- -------- -------- --------- -- -------- -------- -- -------
  Diltiazem (mg) (n=23)     80±35                         220±28   136±82                              60       206±57   190±72       72±27    208±55      0.001
  Verapamil (mg) (n=8)      93±23                         0        93±23                               220±75   0        220±75       173±88   0           1.000
  Nifedipine (mg) (n=12)    33±6                          0        33±6                                40±17    37±15    38±15        38±15    37±15       0.924
  Amlodipine (mg) (n=6)     10                            0        10                                  10       5        7±3          10       5           0.095
  Benidipine (mg) (n=11)    0                             2        2                                   0        7±4      7±4          0        7±4         1.000
  ISMN (mg) (n=14)          20                            40       33±12                               60       42±15    44±15        40±28    42±13       1.000
  ISDN (mg) (n=12)          80                            0        80                                  43±17    40       41±9         50±22    40          0.209
  Nicorandil (mg) (n=14)    10                            15       13±4                                0        17±3     17±3         10       17±3        0.137
  Nitrate tape (mg) (n=2)   0                             0        0                                   10±7     30       10±7         10±7     0           1.000
  Amiodarone (mg) (n=8)     0                             100      100                                 0        114±38   114±38       0        113±35      1.000

ISMN: isosorbide dinitrtae, ISMN: isosorbide mononitrate, ICD: implantable cardioverter-defibrillator

The prognosis after the appropriate ICD shocks
----------------------------------------------

Appropriate ICD shocks were effective in suppressing ventricular tachycardia in 3 patients, ventricular tachycardia or fibrillation in 9 patients and ventricular fibrillation in 21 patients. Three patients with aborted SCD due to coronary spasm, who had undergone the implantation of an ICD, died during the follow-up period. One patient died due to pulseless electrical activity despite the continuous delivery of electrical therapy by the ICD, the second patient died due to intractable ventricular fibrillation, and the third patient died due to electromechanical dissociation and severely reduced left ventricular contraction despite appropriate ICD therapy. With the exception of the 3 patients who died, all 33 who received appropriate ICD shocks were rescued from second ventricular fibrillation/tachycardia. As shown in [Fig. 2](#g002){ref-type="fig"}, 8 patients each from Western and Asian countries received appropriate ICD shocks. Within 12 months, appropriate ICD shocks were recognized in 10 (62.5%) of 16 patients. The details of the periods in which the appropriate ICD shocks were delivered were not found in 17 patients.

![The total population of patients with appropriate ICD shocks in Western and Asian countries. ICD: implantable cardioverter-defibrillator](1349-7235-57-1361-g002){#g002}

Discussion
==========

During the 41-month follow-up period, appropriate ICD shocks were recognized in 24.1% of the patients with aborted SCD due to coronary artery spasm who underwent ICD implantation. Only 15.6% (15/96) of the patients were treated with aggressive medical therapy including two or three calcium-channel antagonists. The rate of appropriate ICD shocks was significantly higher in patients from Western countries than in those from Asian countries; however, the medications did not differ between the two regions. Appropriate ICD shocks resuscitated 33 patients; 3 patients died due to second ventricular fibrillations/tachycardia. The implantation of ICDs in patients with aborted SCD due to coronary spasm was effective in resuscitating these patients from their next life-threatening ventricular arrhythmias.

Although these 33 patients underwent ICD implantation, medications might not have been sufficient for suppressing the patients\' next life-threatening ventricular arrhythmias due to coronary artery spasm. We should administer more calcium-channel antagonists and nitrates/nicorandils in these near-miss patients. We did not find any patients who were treated with aggressive medical therapy among the patients without ICD shocks. Three patients died despite receiving appropriate ICD shocks after aborted SCD. If they had received more aggressive medical therapy, such as two or three calcium-channel antagonists, the implantation of an ICD might have rescued them. The optimal medications in patients with aborted SCD due to coronary spasm remain controversial; however, cardiologists should reconsider administering multiple medications to patients who are at high risk of serious fatal arrhythmias due to coronary spasm.

Pharmacological spasm provocation tests were defined as class I according to the Japanese Circulation Society guidelines ([@B39]), while the European Society of Cardiology and American College of Cardiology/American Heart Association guidelines defined the tests as class IIa or IIb ([@B40],[@B41]). With the exception of cardiologists who worked in small special institutions, Western cardiologists did not perform the pharmacological spasm provocation tests in cardiac catheterization laboratories. In contrast, Asian cardiologists have been performing these tests for more than 30 years. In this series, Asian cardiologists performed pharmacological spasm provocation tests more frequently than their Western counterparts. The incidence of ventricular tachycardia or ventricular fibrillation during pharmacological spasm provocation tests in Asian countries was significantly higher than in Western countries, whereas the rates of cardiogenic shock, acute coronary syndrome and death in Asian countries were remarkably lower in comparison to Western countries ([@B42]). The incidence of coronary artery spasm was three times higher in Asian countries than in Western countries. We had no data about the precise frequency of ICD implantation in patients with aborted SCD due to coronary spasm in Western and Asian countries. Although the medications after ICD implantation did not differ between Western and Asian countries, the rate of appropriate ICD shocks in patients in Western countries was significantly higher in comparison to those in Asian countries. We did not understand the reasons for the higher incidence of appropriate ICD shocks in Western countries. However, these patients might have higher disease activity than Asian patients. Actually, angiographic spontaneous spasm was more often observed in Western countries than in Asian countries.

According to the Japanese Circulation Society (JCS) guidelines for the non-pharmacotherapy of cardiac arrhythmia ([@B43]), ICD implantation was defined as class IIb when patients were at high risk of next fatal arrhythmia, such as ventricular fibrillation or tachycardia due to coronary spasm, irrespective of whether they received appropriate medical therapy. Medical therapy is the first-line treatment for patients with aborted SCD due to coronary spasm. In the clinic, we had no precise strategy for ICD implantation in patients with aborted SCD due to coronary vasospasm. Eschalier et al. reported the clinical use of ergonovine tests under the optimal medications when cardiologists considered the necessity of ICD implantation in patients with aborted SCD due to coronary spasm ([@B32]). We also reported the results of pharmacological spasm provocation testing under patients with refractory spasm who were treated with medical therapy ([@B44]). ICD implantation may not be always necessary for patients with aborted SCD who had life-threatening ventricular arrhythmia and coronary spasm. Actually, in this short article, appropriate ICD shocks were not recognized in three quarters of the patients. Pharmacological spasm provocation tests in patients receiving appropriate medical therapy may become a clinical tool that can be used to differentiate patients with aborted SCD due to coronary spasm require ICD implantation. However, at present, we are of the opinion that ICD implantation in patients with aborted SCD due to coronary spasm may be adequate for classifying a patient as class IIb, because we had no prospective data about the appropriate ICD shocks that were delivered in these patients.

Limitations
-----------

The present study was associated with some limitations. First was a retrospective study. Moreover, there were selection and publication biases in the published papers. Second, the same categorical data were not available to compare each of the issues in all of the 137 patients. We were able to analyze the dosage of calcium channel antagonists or nitrate/nicorandil and coronary risk factors in less than a third of the patients. We tried to analyze these data using a multivariate regression analysis. However, we could not obtain statistically significant results due to the data that were missing in each paper. Further prospective studies will be necessary to investigate the optimal treatments for suppressing the next serious fatal arrhythmia after ICD implantation in patients with aborted SCD due to coronary spasm.

Conclusions
===========

After ICD implantation in patients with aborted SCD due to coronary artery spasm, appropriate ICD shocks were observed in a quarter of these patients during the 41-month follow-up period. Cardiologists should reconsider administering more medications, including two or three calcium channel antagonists, to patients with aborted SCD due to coronary artery spasm as well as ICD implantation.
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